Bonjesta 20/20

Bonjesta 20/20 combines doxylamine succinate and pyridoxine hydrochloride for oral use. This medication is commonly used to alleviate nausea and vomiting during pregnancy. It is manufactured by Exeltis Germany GmbH and is available in the EU market.

Bonjesta 20/20 is primarily used to manage nausea and vomiting associated with pregnancy. The combination of doxylamine succinate, an antihistamine, and pyridoxine hydrochloride, a form of vitamin B6, works together to provide relief. Many women seek this medication when experiencing morning sickness or similar symptoms during pregnancy.

Common effects of Bonjesta 20/20 may include drowsiness, dizziness, and dry mouth. Some users might also experience mild headaches or blurred vision. These effects vary from person to person and are generally temporary.

Bonjesta 20/20 should be used with caution, especially for those with a history of asthma, glaucoma, or urinary retention. It is important to consult a healthcare provider before starting this medication, particularly if you have any pre-existing conditions or are taking other medications.

Bonjesta 20/20 may interact with alcohol, sedatives, and other medications that cause drowsiness. It is advisable to avoid alcohol while taking this medication to prevent increased drowsiness. Always inform your healthcare provider about all medications you are currently taking.